基本信息
浏览量:1
职业迁徙
个人简介
His main research interests include drug development for patients with AML, CML, and MDS and he serves as Co-Investigator for the Oncology Center’s UM1 (early phase drug development) Grant. The Leukemia Program’s clinical trials portfolio has included trials for each of the 8 newly FDA-approved drugs for acute leukemia in the past 2 years.
Dr. Smith has a passion for teaching trainees and has served on the Fellowship Executive Committee since 2010 focusing on the program’s educational platforms. He has won numerous teaching awards in both the Department of Oncology and the Department of Medicine multiple times, and he has a track record of mentoring fellows pursuing clinical-translational research and clinician-educator pathways. In 2020, Dr. Smith was awarded membership in the prestigious Miller Coulson Academy for Excellence in Clinical Care.
He is a member of the American Society of Hematology, the American Society of Clinical Oncology and the American Association for Cancer Research. He has served on the National Comprehensive Cancer Network guideline panel for CML since 2001 and previously served on the AML panel from 2001-2015. Dr. Smith has extensive experience in the regulatory aspects of drug development and he currently serves as the Chair of the Johns Hopkins Institutional Review Board #2.
Dr. Smith has a passion for teaching trainees and has served on the Fellowship Executive Committee since 2010 focusing on the program’s educational platforms. He has won numerous teaching awards in both the Department of Oncology and the Department of Medicine multiple times, and he has a track record of mentoring fellows pursuing clinical-translational research and clinician-educator pathways. In 2020, Dr. Smith was awarded membership in the prestigious Miller Coulson Academy for Excellence in Clinical Care.
He is a member of the American Society of Hematology, the American Society of Clinical Oncology and the American Association for Cancer Research. He has served on the National Comprehensive Cancer Network guideline panel for CML since 2001 and previously served on the AML panel from 2001-2015. Dr. Smith has extensive experience in the regulatory aspects of drug development and he currently serves as the Chair of the Johns Hopkins Institutional Review Board #2.
研究兴趣
论文共 288 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
HAEMATOLOGICAno. 3 (2024): 948-952
Kendra L Sweet,Jorge E Cortes,Jane F Apperley, Mel Mann,Michael J Mauro,Vivian G Oehler,Cristina Ruiz,Charles A Schiffer,Lori A Ehrlich, Gulsum E Pamuk,Joseph Wynne,Gautam U Mehta,
Clinical cancer research : an official journal of the American Association for Cancer Researchno. 1 (2024): 237-238
Cell Death & Differentiationpp.1-12, (2024)
crossref(2023)
Leukemia & lymphomano. 4 (2023): 846-855
Ying Ye,Michael A. McDevitt,Mingzhou Guo,Wei Zhang, Oliver Galm,Steven D. Gore,Judith E. Karp,Jaroslaw P. Maciejewski, Jeanne Kowalski,Hua-Ling Tsai,Lukasz P. Gondek,Hsing-Chen Tsai,
crossref(2023)
crossref(2023)
Amir T. Fathi,B. Douglas Smith, Anne Angiolillo,Gary Binder,Jianan Hui, Rachel Guo,Claudio Cerchione
Clinical Lymphoma, Myeloma & Leukemia (2023): S163-S302
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn